/
Ser/thr phosphatases: the new frontier for myeloid leukemia therapy?
- Smith, Amanda M., Roberts, Kathryn G., Verrills, Nicole M.
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers
- Roberts, Kathryn G., Smith, Amanda M., Sim, Alistair T. R., Ashman, Leonie K., Verrills, Nicole M., McDougall, Fiona, Carpenter, Helen, Horan, Martin, Neviani, Paolo, Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Perrotti, Danilo
Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection
- Skelding, Kathryn A., Hickey, Danica K., Horvat, Jay C., Bao, Shisan, Roberts, Kathryn G., Finnie, Jane M., Hansbro, Philip M., Beagley, Kenneth W.
Are you sure you would like to clear your session, including search history and login status?